Home LiteratureArticle Details
PMID: 10948142 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Shiga toxin-induced tumor necrosis factor alpha expression: requirement for toxin enzymatic activity and monocyte protein kinase C and protein tyrosine kinases.

Infection and immunity ·Vol. 68 ·No. 9 ·2000-09-00 ·Pages 5183-9

Foster GH, Armstrong CS, Sakiri R, Tesh VL

Abstract

Infections with Shiga toxin (Stx)-producing bacteria cause bloody diarrhea which may progress to life-threatening complications, including acute renal failure and neurological abnormalities. The precise mechanism of disease progression is unclear, although evidence suggests that the localized production of the host proinflammatory cytokines tumor necrosis factor alpha (TNF-alpha) and interleukin-1 may exacerbate toxin-mediated vascular damage. Purified Stxs have been demonstrated to elicit proinflammatory cytokine synthesis from human peripheral blood mononuclear cells and monocytic cell lines in vitro. To understand toxin-monocyte interactions required for cytokine synthesis, we have treated differentiated THP-1 cells with purified wild-type toxins, enzymatic mutants, or B subunits and measured TNF-alpha production. Our data suggest that A subunit enzymatic activity is essential for cytokine production. THP-1 cells were treated with a series of protein kinase C (PKC), PKA, and protein tyrosine kinase inhibitors to examine the role of intracellular signaling molecules in Stx-mediated cytokine production. Treatment of cells with PKC and tyrosine kinase inhibitors blocked TNF-alpha secretion by Stx-stimulated THP-1 cells. Stx treatment directly activated PKC, which occurred at a point upstream of transcriptional activation of the gene encoding TNF-alpha.

MeSH Terms
Bacterial Toxins/toxicity Cyclic AMP-Dependent Protein Kinases/physiology Humans Monocytes/enzymology Protein Kinase C/physiology Protein Serine-Threonine Kinases/physiology Protein-Tyrosine Kinases/physiology RNA, Messenger/analysis Shiga Toxins Tumor Cells, Cultured Tumor Necrosis Factor-alpha/biosynthesis,genetics
Chemicals
Bacterial Toxins RNA, Messenger Shiga Toxins Tumor Necrosis Factor-alpha Protein-Tyrosine Kinases Protein Serine-Threonine Kinases Cyclic AMP-Dependent Protein Kinases Protein Kinase C
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Foster G H
Department of Medical Microbiology and Immunology, Texas A&M University Health Science Center, College Station, Texas 77843-1114, USA.
Armstrong C S
Sakiri R
Tesh V L
References (41)
41 references, click to expand
  1. Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells.
    Infect Immun. 1999 Nov;67(11):5985-93 PMID: 10531258
  2. Lipopolysaccharide induces activation of the Raf-1/MAP kinase pathway. A putative role for Raf-1 in the induction of the IL-1 beta and the TNF-alpha genes.
    J Immunol. 1994 Dec 15;153(12):5740-9 PMID: 7989771
  3. Quantitative microtiter cytotoxicity assay for Shigella toxin.
    J Clin Microbiol. 1980 Sep;12(3):361-6 PMID: 7012172
  4. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.
    Biochemistry. 1984 Oct 9;23(21):5036-41 PMID: 6238627
  5. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.
    J Infect Dis. 1985 May;151(5):775-82 PMID: 3886804
  6. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.
    J Exp Med. 1986 Jun 1;163(6):1391-404 PMID: 3519828
  7. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
    Anal Biochem. 1987 Apr;162(1):156-9 PMID: 2440339
  8. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.
    Eur J Biochem. 1988 Jan 15;171(1-2):45-50 PMID: 3276522
  9. Direct cytotoxic action of Shiga toxin on human vascular endothelial cells.
    Infect Immun. 1988 Sep;56(9):2373-8 PMID: 3044997
  10. Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes.
    J Biol Chem. 1989 Jan 5;264(1):596-601 PMID: 2642481
  11. Globotetraosylceramide is recognized by the pig edema disease toxin.
    J Biol Chem. 1989 Jul 25;264(21):12520-5 PMID: 2663859
  12. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.
    Infect Immun. 1990 Mar;58(3):611-8 PMID: 2155181
  13. A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit.
    Infect Immun. 1990 Sep;58(9):2977-82 PMID: 2201641
  14. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells.
    J Infect Dis. 1991 Aug;164(2):344-52 PMID: 1649877
  15. Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.
    Infect Immun. 1991 Nov;59(11):4173-9 PMID: 1937774
  16. An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine.
    Infect Immun. 1992 Feb;60(2):485-90 PMID: 1730480
  17. Bacterial lipopolysaccharide induces tyrosine phosphorylation and activation of mitogen-activated protein kinases in macrophages.
    J Biol Chem. 1992 Jul 25;267(21):14955-62 PMID: 1321821
  18. Growth factor signaling by receptor tyrosine kinases.
    Neuron. 1992 Sep;9(3):383-91 PMID: 1326293
  19. Tumor necrosis factor alpha induces endothelial galactosyl transferase activity and verocytotoxin receptors. Role of specific tumor necrosis factor receptors and protein kinase C.
    Blood. 1995 Feb 1;85(3):734-43 PMID: 7530504
  20. The hemolytic uremic syndrome.
    Pediatr Clin North Am. 1995 Dec;42(6):1505-29 PMID: 8614598
  21. Differentiation-associated toxin receptor modulation, cytokine production, and sensitivity to Shiga-like toxins in human monocytes and monocytic cell lines.
    Infect Immun. 1996 Apr;64(4):1173-80 PMID: 8606075
  22. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages.
    Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2774-8 PMID: 8610116
  23. Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release.
    Blood. 1996 Jul 1;88(1):174-83 PMID: 8704172
  24. Endotoxin signal transduction in macrophages.
    J Leukoc Biol. 1996 Jul;60(1):8-26 PMID: 8699127
  25. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway.
    Mol Med. 1994 Nov;1(1):93-103 PMID: 8790605
  26. Ribotoxic stress response: activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28S rRNA.
    Mol Cell Biol. 1997 Jun;17(6):3373-81 PMID: 9154836
  27. Phosphatidylinositol 3-kinase-dependent activation of protein kinase C-zeta in bacterial lipopolysaccharide-treated human monocytes.
    J Biol Chem. 1997 Jun 27;272(26):16445-52 PMID: 9195953
  28. Sensitization of human umbilical vein endothelial cells to Shiga toxin: involvement of protein kinase C and NF-kappaB.
    Infect Immun. 1997 Aug;65(8):3337-44 PMID: 9234795
  29. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK.
    Mol Cell Biol. 1997 Nov;17(11):6274-82 PMID: 9343388
  30. The extended protein kinase C superfamily.
    Biochem J. 1998 Jun 1;332 ( Pt 2):281-92 PMID: 9601053
  31. Shiga toxin type 1 activates tumor necrosis factor-alpha gene transcription and nuclear translocation of the transcriptional activators nuclear factor-kappaB and activator protein-1.
    Blood. 1998 Jul 15;92(2):558-66 PMID: 9657756
  32. LPS-binding proteins and receptors.
    J Leukoc Biol. 1998 Jul;64(1):25-32 PMID: 9665271
  33. Endotoxin activation of mitogen-activated protein kinase in THP-1 cells; diminished activation following endotoxin desensitization.
    J Leukoc Biol. 1998 Aug;64(2):259-64 PMID: 9715266
  34. Induction of cytokines in a human colon epithelial cell line by Shiga toxin 1 (Stx1) and Stx2 but not by non-toxic mutant Stx1 which lacks N-glycosidase activity.
    FEBS Lett. 1999 Jan 15;442(2-3):231-4 PMID: 9929007
  35. LPS-Induced NF-kappaB activation and TNF-alpha release in human monocytes are protein tyrosine kinase dependent and protein kinase C independent.
    J Surg Res. 1999 May 1;83(1):69-74 PMID: 10210645
  36. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.
    Blood. 1992 Dec 1;80(11):2755-64 PMID: 1333300
  37. Protein kinase C regulates TNF-alpha production by human monocytes.
    Eur Cytokine Netw. 1993 Jan-Feb;4(1):31-7 PMID: 8490103
  38. Characterization of non-toxic mutant toxins of Vero toxin 1 that were constructed by replacing amino acids in the A subunit.
    Microb Pathog. 1993 Sep;15(3):169-76 PMID: 8271917
  39. Involvement of protein kinase C and protein tyrosine kinase in lipopolysaccharide-induced TNF-alpha and IL-1 beta production by human monocytes.
    J Immunol. 1994 Aug 15;153(4):1818-24 PMID: 7519214
  40. Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages.
    Infect Immun. 1994 Nov;62(11):5085-94 PMID: 7927791
  41. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1).
    Int J Cancer. 1980 Aug;26(2):171-6 PMID: 6970727
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
2000-09-00
Pages
5183-9
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC101776
Subset
IM
Grants
NIAID NIH HHS · R01 AI034530 · United States
NIAID NIH HHS · R29 AI034530 · United States
NIAID NIH HHS · AI-34530 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com